Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03767348
Title Study of RP1 Monotherapy and RP1 in Combination With Nivolumab
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Replimune Inc.
Indications

Merkel cell carcinoma

Advanced Solid Tumor

basal cell carcinoma

urinary bladder cancer

skin squamous cell carcinoma

skin cancer

melanoma

basosquamous carcinoma

Therapies

Nivolumab + RP1

RP1

Age Groups: senior | adult
Covered Countries USA | FRA | ESP | DEU


No variant requirements are available.